.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
QuintilesIMS
Boehringer Ingelheim
Cerilliant
Merck
Fuji
Teva
McKinsey
Farmers Insurance
Medtronic

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090039

« Back to Dashboard
NDA 090039 describes METHOTREXATE SODIUM PRESERVATIVE FREE, which is a drug marketed by Accord Hlthcare, Hospira, Mylan Labs Ltd, Sandoz Inc, West-ward Pharms Int, and Pharmachemie Bv, and is included in twelve NDAs. It is available from eight suppliers. Additional details are available on the METHOTREXATE SODIUM PRESERVATIVE FREE profile page.

The generic ingredient in METHOTREXATE SODIUM PRESERVATIVE FREE is methotrexate sodium. There are twenty drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the methotrexate sodium profile page.

Summary for NDA: 090039

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Immunological Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 090039

Suppliers and Packaging for NDA: 090039

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METHOTREXATE SODIUM PRESERVATIVE FREE
methotrexate sodium
INJECTABLE;INJECTION 090039 ANDA Sandoz Inc 66758-040 66758-040-02 10 VIAL, SINGLE-DOSE in 1 CARTON (66758-040-02) > 2 mL in 1 VIAL, SINGLE-DOSE (66758-040-01)
METHOTREXATE SODIUM PRESERVATIVE FREE
methotrexate sodium
INJECTABLE;INJECTION 090039 ANDA Sandoz Inc 66758-040 66758-040-08 10 VIAL, SINGLE-DOSE in 1 CARTON (66758-040-08) > 10 mL in 1 VIAL, SINGLE-DOSE (66758-040-07)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 50MG BASE/2ML (EQ 25MG BASE/ML)
Approval Date:Mar 31, 2009TE:APRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 250MG BASE/10ML (EQ 25MG BASE/ML)
Approval Date:Mar 31, 2009TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Moodys
Merck
Chinese Patent Office
Colorcon
Cerilliant
McKesson
Chubb
UBS
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot